ImmunoGen
IMGN
#2225
Rank
$8.72 B
Marketcap
$31.23
Share price
0.00%
Change (1 day)
134.11%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: $8.72 Billion USD

On April 12, 2024 ImmunoGen had a market cap of $8.72 Billion USD. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024$8.72 B9.93%
2023$7.93 B624.81%
2022$1.09 B-32.96%
2021$1.63 B30.04%
2020$1.25 B63.86%
2019$0.76 B6.88%
2018$0.71 B-15.41%
2017$0.84 B376%
2016$0.17 B-84.92%
2015$1.18 B124.94%
2014$0.52 B-58.2%
2013$1.25 B17.03%
2012$1.07 B21.27%
2011$0.88 B40.52%
2010$0.62 B39.84%
2009$0.45 B106.73%
2008$0.21 B22.39%
2007$0.17 B-15.67%
2006$0.21 B0.18%
2005$0.21 B-41.61%
2004$0.36 B76.06%
2003$0.20 B56.69%
2002$0.13 B-80.16%
2001$0.65 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
$564.90 B 6,375.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$293.40 B 3,263.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$152.26 B 1,645.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$992.48 B 11,276.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$197.19 B 2,160.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$116.78 B 1,238.58%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
$117.30 B 1,244.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
$43.15 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA